News

Ongoing debates question whether or not lipid lowering in elderly patients offers similar clinical benefit as in younger patients.

The Regeneron monoclonal antibodies are linked to reduced risk of hospitalization or ED visit among mild-to-moderate COVID-19 cases.

An interview with a pain specialist on advancing alternative pain therapy options.

Lonafarnib was linked to improved mortality over a maximum of 11 years follow-up, according to supporting data.

Even study enrollees who never smoked traditional cigarettes face a heightened risk of respiratory disease if they used e-cigarettes.

The shortage of kidney donors begs a need to consider safe approaches to expand the donor pool.

HIV care may help enable better treatment for HCV infectious.

The first-line atypical antipsychotic was linked to better outcomes in patients than comparators aripiprazole and olanzapine.

Investigators used CDC HCV infographic posters to remind healthcare providers and offer educational resources about screening.

C. diff infections have decreased during the ongoing pandemic.

A pediatric dermatologist discusses dupilumab for pediatric atopic dermatitis in addition to promising new therapies.

Newborns who were given a probiotic had lower rates of atopic dermatitis and lower symptom scores, according to a new study.

Investigators find frailty is a key risk factor for age-related cognitive dysfunction and dementia.

A week-long treatment program prevented HCV transmission in 88% of cases.

In data from several studies presented at AHA 2020, investigators tout bempedoic acid in patients with atherosclerotic cardiovascular disease and/or heterozygous familial hypercholesterolemia.

A uveitis specialist breaks down what occurs during the uveitis-dedicated event and comments on its importance.

Raymond Douglas, MD, PhD discusses how the COVID-19 pandemic has affected his clinical practice and potentially accelerated technological innovation as a whole.

The agency did not find any efficacy or safety issues regarding the potential treatment for adults with schizophrenia or bipolar I disorder.

A team of researchers share strategies to "map out" pre-cancer lung risks in their greater goal of interception.

A post-hoc analysis of the CANTREAT trial finds similar GA frequency, characteristics, and surface area between patients in treat-and-extend and once-monthly regimen cohorts.

There was very little difference found in visual acuity whether or not anti-VEGF treatments were used.

In data presented at AAO 2020, investigators test imaged guided intravitreal aflibercept injections for sight improvements.

A recent study presented at AAO 2020 reports that increased choroid vascular flow was noted in both small and large vessels in patients with non-vitrectomized eyes.

A new study from AAO 2020 is the first to show a significant association between peripapillary vessel density loss and progression of diabetic retinopathy.

Adamis plans to address agency concerns regarding the naloxone injection application.

Preliminary data from a phase 3 trial has met its trigger point in total COVID-19 infections, and the interim findings look good for mRNA-1273.

A discrepancy regarding a pre-licensing inspection of a third-party manufacturing facility led to the Complete Response Letter.

A new IRIS registry analysis reports that many patients with geographic atrophy do not continue follow-up after initial visit or consultation.